Poland· PL-100473389

Tezeo

A telmisartan product containing telmisartanum, registered in Poland by InPharm Sp. z o.o.. The same ATC class is registered in 17 of our 19 countries.

ATC C09CA07

Checked against URPL (Poland) on

Informational only — not a medical device.

SOURCE REGISTER · PLURPL (Poland)normalisedTezeoATCC09CA07REGISTER NO.PL-100473389PACKS LISTED3CHECKEDSeptember 27, 2026

Where it is registered

Telmisartan is registered in 17 of 19 countries.

Countries holding a registration under ATC C09CA07 (telmisartan), each read from that country’s own register.

  • This record: Poland, from URPL (Poland)
  • 10 of them publish a price we can compare per daily dose

Telmisartan · ATC C09CA07

17 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Franceprice
  • Germany
  • Icelandprice
  • Ireland
  • Italyprice
  • Netherlands
  • Norwayprice
  • Polandprice
  • Sweden
  • Switzerlandprice
  • United Kingdom
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of telmisartan costs, country by country.

Normalised to the WHO defined daily dose (40 mg), the median price runs from $0.14 in France to $0.71 in Switzerland — a ×5.0 gap.

  • 4 markets with a comparable price for this class
  • Public list prices, converted to USD at the rate date shown
  • US figures are pharmacy acquisition cost (CMS NADAC), not retail

Telmisartan · price per daily dose (40 mg)

USD · FX 28 Sept 2026

  • CH Switzerland$0.71
  • IT Italy$0.16
  • US United States$0.15 (acquisition cost)
  • FR France$0.14
Median listed price per WHO defined daily dose, in each market that publishes a price. US = pharmacy acquisition cost (CMS NADAC), not a retail price. Open the full comparison

The record

At a glance

URPL (Poland)
Active substance
Telmisartanum
Manufacturer
InPharm Sp. z o.o.
Country
Poland (PL)
ATC code
C09CA07
ATC class
Telmisartan
Defined daily dose
40 mg, O
Reimbursed
Not published by this register
Source register
URPL (Poland)
Last checked
September 27, 2026

Packs & prices · 3

  • gtin
    05909991496326
  • gtin
    05909991496333
  • gtin
    05909991496340

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

334 interactions on record for telmisartan.

Graded by severity as the source publishes them — 7 severe. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan

Telmisartan · interactions on record

334 records

  • 7 severe
  • 121 moderate
  • 1 minor
  • 124 info

Most severe, free to view

  • Potassium chlorideA12BA01severe
  • Potassium citrateA12BA02severe
  • Potassium gluconateA12BA05severe
  • Potassium chlorideB05XA01severe

81 more interactions with mechanism and management, from a commercially licensed source.

Sign in to check
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Telmisartan in 17 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All telmisartan products

Authorised across Europe · EMA

The same active substance is authorised in 26 EEA countries. Names it is sold under:

  • Austria · Actelsar, Telmicard
  • Belgium · Telmisartan Eg, Telmisartan Teva
  • Bulgaria · Telsart, Tезео
  • Cyprus · Telmisartan Jubilant
  • Czechia · Telmisartan Egis, Telmisartan Ratiopharm
  • Germany · Telmisartan 1 A Pharma, Telmisartan Abz
  • Denmark · Telmisartan Medical Valley, Telmisartan Stada
  • Estonia · Telmisartaan Amarox, Telmisartan Ratiopharm
  • Spain · Telmark, Telmisartán Almus
  • Finland · Telmark, Telmisartan Amarox
  • France · Telmisartan Amarox, Telmisartan Arrow
  • United Kingdom (Northern Ireland) · Telmisartan Accord Healthcare, Telmisartan Amarox
  • Hungary · Tanydon, Telmisartan Egis
  • Ireland · Mirpresoc, Telmisartan Accord Healthcare Ireland
  • Iceland · Kinzalmono, Micardis
  • Italy · Telmisartan Almus, Telmisartan Alter
  • Liechtenstein · Kinzalmono, Micardis
  • Lithuania · Telmisartan Ingen Pharma, Telmisartan Inteli
  • Luxembourg · Telmisartan Eg, Telmisartan Micro Labs
  • Latvia · Telmisartan Ratiopharm, Tezeo
  • Netherlands · Telmisartan 1a Pharma, Telmisartan Amarox
  • Norway · Kinzalmono, Micardis
  • Portugal · Diterpris, Mirpresoc
  • Romania · Tezeo
  • Sweden · Telmark, Telmisartan Amarox
  • Slovakia · Telmark, Telmisartan Egis

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of URPL (Poland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/ca55d455-5151-43b8-a7dd-4db235c07b02
GET /v1/drugs/ca55d455-5151-43b8-a7dd-4db235c07b02?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Tabletki",
  "source": "urpl",
  "strength": "80 mg",
  "packaging": "05909991496326 ¦ Rp ¦ 146888\n30 tabl.\n05909991496333 ¦ Rp ¦ 146889\n60 tabl.\n05909991496340 ¦ Rp ¦ 146890\n90 tabl.",
  "substance": "Telmisartanum 80 mg",
  "common_name": "Telmisartanum",
  "pl_product_id": "100473389",
  "pozwolenie_nr": "342/22",
  "auth_procedure": "IR",
  "authorisation_validity": "2027-09-20"
}

See everything about telmisartan.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.